Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity
about
Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UseMercaptopurine metabolite levels are predictors of bone marrow toxicity following high-dose methotrexate therapy of childhood acute lymphoblastic leukaemia.Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment responseThiopurine S-Methyltransferase and Methylenetetrahydrofolate Reductase Polymorphisms in Leukemia.Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
P2860
Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Myelotoxicity after high-dose ...... ine methyltransferase activity
@ast
Myelotoxicity after high-dose ...... ine methyltransferase activity
@en
type
label
Myelotoxicity after high-dose ...... ine methyltransferase activity
@ast
Myelotoxicity after high-dose ...... ine methyltransferase activity
@en
prefLabel
Myelotoxicity after high-dose ...... ine methyltransferase activity
@ast
Myelotoxicity after high-dose ...... ine methyltransferase activity
@en
P2093
P2860
P50
P1476
Myelotoxicity after high-dose ...... ine methyltransferase activity
@en
P2093
Anne Grete Bechensteen
Arja Harila-Saari
Birgitte Lausen
Jesper Heldrup
Mette Levinsen
Olafur G Jonsson
Ulrikka Nygaard
P2860
P2888
P356
10.1007/S00280-014-2613-7
P577
2014-10-28T00:00:00Z
P5875
P6179
1015805633